Mentor almost free of urology
This article was originally published in The Gray Sheet
Executive Summary
Firm announces definitive agreement to sell its Surgical Urology and Clinical and Consumer Healthcare divisions to Coloplast for $463 mil. on May 17. The transaction will enable Mentor to focus on the development of its aesthetics business (1"The Gray Sheet" April 3, 2006, p. 7). Mentor also reported that it has initiated a four-month Phase 1 study of its botulinum toxin type A product to treat pain associated with adult onset spasmodic torticollis/cervical dystonia...